Skip to content

Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL

Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery and Their Aftercare Situation During the COVID-19 Pandemic - Long-term Follow-up of the Randomized Trial DIQOL

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04930016
Acronym
DIQOLFollow-up
Enrollment
208
Registered
2021-06-18
Start date
2021-04-14
Completion date
2021-10-07
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colorectal Neoplasms, Quality of Life, Survivorship

Keywords

quality of life, colorectal cancer, complex intervention, survivorship, health services research

Brief summary

This observational follow-up study of the randomized trial (RCT) DIQOL investigates long-term effects of an intervention with quality of life (QoL) diagnosis and therapy on present QoL, survival, and recurrence-free survival of colorectal cancer survivors more than 5 years after surgery. Moreover, patients' experiences with aftercare for colorectal cancer during the COVID-19 pandemic and their recollections of their illness and therapy are examined.

Detailed description

In a complex intervention a clinical pathway with quality of life (QoL) diagnosis and tailored therapy had been developed for patients with colorectal cancer and its effectiveness was evaluated in a randomized trial (RCT DIQOL, NCT02321813, Klinkhammer-Schalke et al, 2020). In the RCT DIQOL a total of 220 patients were randomised (1:1) into two groups: a care pathway, including QoL-profiles consisting of 13 QoL scales plus specific therapeutic recommendations forwarded to the patient's doctor (intervention) or standard postoperative care (control). QoL was measured (EORTC QLQ-C30, QLQ-CR29) in all patients after surgery and during aftercare (3, 6, 12, 18 months postoperatively). A need for QoL therapy was defined as a score \<50 points on at least one QoL scale. It was demonstrated that the proportion of patients with a need for QoL therapy was significantly lower in intervention group patients at 12 months after surgery (primary endpoint). Until now, it is unclear whether there are also long-term benefits of QoL diagnosis and therapy. Therefore, the aim of this observational, cross-sectional follow-up study of the RCT DIQOL is to investigate long-term effects of the intervention on present QoL (EORTC QLQ-C30, QLQ-CR29), overall survival, and recurrence-free survival more than 5 years after surgery by comparing former intervention and control group patients. Moreover, participants will be asked for their experiences during aftercare in relation of the COVID-19 pandemic and for their recollection of their illness and therapy. Data are collected via questionnaire.

Interventions

BEHAVIORALQuality of life diagnosis and therapy during the completed RCT DIQOL

Quality of life measurement, diagnosis, and tailored therapy (pain therapy, psychotherapy, social support, nutrition, stoma care, physiotherapy, fitness)

Sponsors

Tumor Center Regensburg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* former participants of the RCT DIQOL with a primary diagnosis of colorectal cancer between 01/2014 and 10/2015 who did not refuse to participate during the RCT * informed consent

Exclusion criteria

\- none -

Design outcomes

Primary

MeasureTime frameDescription
need for QoL therapy of colorectal cancer survivors>5 years after surgery for colorectal cancerproportion of patients in both groups with a need for QoL therapy (\<50 points in at least one dimension) more than 5 years after surgery
specific need for QoL therapy of colorectal cancers survivors in specific QoL dimensions>5 years after surgery for colorectal cancerrates of patients with a need for QoL therapy in each single dimension of the QoL-profile more than 5 years after surgery

Secondary

MeasureTime frameDescription
overall survivalsurgery for colorectal cancer (01/2014-10/2015) up to 10/2021survival after surgery for colorectal cancer
recurrence-free survivalsurgery for colorectal cancer (01/2014-10/2015) up to 10/2021recurrence-free survival after surgery for colorectal cancer
aftercare of colorectal cancer survivors during the COVID-19 pandemic>5 years after surgery for colorectal cancerself-created questionnaire with quantitative questions asking whether and how the COVID-19 pandemic affected ´aftercare
colorectal cancer survivors' recollections of their illness an therapy>5 years after surgery for colorectal cancerself-created questionnaire with three qualitative questions asking for worst experiences during the colorectal cancer episode, positive aspects of the illness, and any advice survivors would give to newly diagnosed patients

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026